Advancing the Medical Writing profession: The Joint Position Statement on the Role of Professional Medical Writers

Chris Winchester

Volume 26, Issue 1 - Writing better

Advancing the Medical Writing profession: The Joint Position Statement on the Role of Professional Medical Writers

Author: Chris Winchester

Abstract

A wintry London in January saw the release of the first joint position statement on the role ofthe professional medical writer (page 7). But why do we need such a statement and what does it say? The Executive Committee identified the need to update our guidelines on medical writing, and Sam Hamilton approached Art Gertel and me in May last year about the possibility of a joint position statement endorsed by both the American Medical Writers Association (AMWA) and EMWA. When the International Society for Medical Publication Professionals (ISMPP) also said that they would come on board, we knew we were onto something. Eight months later, at the 2017 European meeting of ISMPP, the AMWA–EMWA–ISMPP Joint Position Statement on the Role of Professional Medical Writers was launched.

Download the full article

References

Hamilton CW, Royer MG. AMWA position statement on the contributions of medical writers to scientific publications. Am Med Writ Assoc J 2003;18:13–16.
Jacobs A, Wager E. European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications. Curr Med Res Opin 2005;21:317–22.
ISMPP. Position Statement: the role of the professional medical writer. Tarrytown NY, USA: International Society for Medical Publication Professionals/2011 [cited 30 Sep 2016 ]. Available from: http://www.ismpp.org/assets/docs/Initiatives/advocacy/ismpp_ghost_writing_vs_professional_medical_writing_oct_2011.pdf
Marusic A, Hren D, Mansi B et al. Five-step authorship framework to improve transparency in disclosing contributors to industry-sponsored clinical trial publications. BMC Med 2014;12:197.
Wager E, Woolley K, Adshead V et al. Awareness and enforcement of guidelines for publishing industry-sponsored medical research among publication professionals: the Global Publication Survey. BMJ Open 2014;4:e004780.
Woolley K, Lew RA, Stretton S et al. Lack of involvement of medical writers and the pharmaceutical industry in publications retracted for misconduct: a systematic, controlled, retrospective study. Curr Med Res Opin 2011;27:1175–82.
Jacobs A. Adherence to the CONSORT guideline in papers written by professional medical writers. Write Stuff 2010;19:196–199.
Gattrell WT, Hopewell S, Young K et al. Professional medical writing support and the quality of randomised controlled trial reporting: a cross-sectional study. BMJ Open 2016;6:e010329.
Shah S, Nair S, Patil A et al. Role of medical publication professional in timely dissemination and transparent reporting of clinical data [poster]. Curr Med Res Opin 2016;32(Suppl 1):S12.
Gattrell W, Maisonobe P, de Abada M. Outcome reporting, funding source and medical writing support in publications evaluated in the COMPare project. Presented at the 2017 European Meeting of the International Society for Medical Publication Professionals (ISMPP), London, 17–18 January, 2017 (poster). [cited 2017 Jan 24]. Available from: http://www.ipsencongressposters.com/ISMPP2017/Poster9_Gattrell.pdf

Volume 26, Issue 1 - Writing better

Advancing the Medical Writing profession: The Joint Position Statement on the Role of Professional Medical Writers

Author: Chris Winchester

Abstract

References

Search

Articles

Member Login

Links

Editoral Board